期刊文献+

轻度认知障碍及阿尔茨海默病患者外周血淋巴细胞中蛋白磷酸酯酶-2A的改变 被引量:4

Alterations of protein phosphatase-2A in peripheral lymphocytes in mild cognition impairment and Alzheimer's disease
原文传递
导出
摘要 目的探讨轻度认知功能障碍(MCI)及阿尔茨海默病(AD)患者外周血淋巴细胞蛋白磷酸酯酶-2A(PP-2A)的变化。方法用放射性配体结合试验检测11名健康对照者、11例 MCI 患者及11例 AD 患者外周血淋巴细胞 PP-2A 的活性,并用 Western blot 检测 PP-2A 蛋白的表达。结果 MCI 组外周血淋巴细胞 PP-2A 活性(0.71±0.12)及蛋白表达(0.80±0.05)与健康对照组[分别为(1.01±0.09)和(0.96±0.07)]相比明显降低(均 P<0.01);AD 组 PP-2A 活性(0.64±0.11)及蛋白表达-(0.76+0.06)亦明显降低,与对照组相比差异有统计学意义(均 P<0.01);AD 组 PP-2A 活性及蛋白表达比 MCI 组有降低的趋势,但差异无统计学意义。结论 MCI 及 AD 患者外周血淋巴细胞 PP-2A 的活性及表达降低,在 MCI 的诊断中可能有参考价值,同时亦可能对 AD 的诊断有一定的潜在的意义。 Objective To explore the alterations of protein phosphatase-2A (PP-2A) in lymphocytes in mild cognition impairment (MCI) and Alzheimer' s disease (AD). Methods The activity PP-2A of was measured by 32p liquid seintillography for incorporated radioactivity in control group( n = 11 ), the MCI group(n = 11 ), and the AD group(n = 11 ). The expression of PP-2A was determined by Western blot. Results In the control group, the activity of PP-2A ( 1.01 ± 0. 09) and the expression of PP-2A (0. 96 ±0. 07) were high while in the MCI group, the activity of PP-2A (0. 71 ±0. 12) and the expression of PP-2A (0. 80 ± 0. 05 ) were decreased ( both P 〈 0. 01 ), the activity of PP-2A (0. 64 ± 0. 11 ) and the expression of PP-2A (0. 76 ± 0. 06) were also decreased (both P 〈 0. 01 )in the AD group compared with control group. Conclusion Low levels of activity and expression of PP-2A, which implies a diagnosis in MCI and AD, are induced in lymphoeytes.
出处 《中华神经科杂志》 CAS CSCD 北大核心 2007年第10期652-654,共3页 Chinese Journal of Neurology
基金 中国博士后科学基金(20060390635) 上海市科委重大基础研究项目(07DJ14005) 上海市市级医院新兴前沿技术联合攻关基金(SHDC12006108)
关键词 认知障碍 阿尔茨海默病 淋巴细胞 磷蛋白磷酸酶 Cognition impairment Alzheimer disease Lymphocyte Phosphoprotein phosphatase
  • 相关文献

参考文献9

  • 1Petersen RC, Smith GE, Waling SC, et al. Mild cognitive impairment: clinical characterization and outcome. Arch Neurol, 1999, 56:303-308.
  • 2Ren QG, Liao XM, Wang ZF, et al. The involvement of glycogen synthase kinase-3 and protein phosphatase-2A in lactacystin-induced tau accumulation. FEBS Lett, 2006, 580: 2503-2511.
  • 3曲忠森,赵永波,刘文文,王建枝.糖尿病大鼠脑GSK-3与PP-2A失调诱导tau蛋白过度磷酸化[J].生物化学与生物物理进展,2006,33(8):789-794. 被引量:6
  • 4Iqbal K, Grundke-Iqbal I. Pharmacological approaches of neurofibrillary degeneration. Curr Alzheimer Res, 2005, 2 : 335- 341.
  • 5Hye A, Kerr F, Archer N, et al. Glycogen synthase kinase-3 is increased in white cells early in Alzheimer' s disease. Neurosci Lett, 2005, 373:1-4.
  • 6Gong CX, Singh TJ, Grundke-Iqbal I, et al. Phosphoprotein phosphatase activities in Alzheimer disease brain, J Neurochem, 1993, 61:921-927.
  • 7赵永波.轻度认知障碍及其进展[J].河南大学学报(医学版),2005,24(2):1-4. 被引量:11
  • 8Mann RK, Bamezai R. Rotein phosphatase-1 inhibition induces high SCEs in normal whole blood cultures, Indian J Exp Biol, 1995, 33:710-711.
  • 9Giunti D, Borsellino G, Benelli R, et al. Phenotypie and functional analysis of T cells homing into the CSF of subjects with inflammatory diseases of the CNS. J Leukoc Biol, 2003, 73:584- 590.

二级参考文献34

  • 1徐淑云 卞如濂 陈修.药理实验方法学[M].北京:人民卫生出版社,2002.1042-1058.
  • 2Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos E, Kokmen E. Mild cognitive impairment. Clinical characterization and outcome[J]. ArchNeurol, 1999,56:303,308.
  • 3Petersen RC, Steven JS, Ganguli MD, et al. Practice parameter: early detection of dementia: mild cognitive impairment (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology[J]. Neurology, 2001,56:1133,1142.
  • 4Morris JC.Dementia Update 2003[J]. Alzheimer Dis Assoc Disord, 2003,17:245,258.
  • 5Unverzagt FW, Gao S, Baiyewu O, et al. Prevalence of cognitive impairment: data from the Indianapolis study of health and aging[J]. Neurology, 2001,57:1655,1662.
  • 6Chertkow H. Mild cognitive impairment[J]. Curr Opin Neurol, 2002,15(4):401-7.
  • 7Petersen RC, Doody R, Kurz A, et al. Current concepts in mild cognitiveimpairment[J]. Arch Neurol, 2001,58:1985,1992.
  • 8Ritchie K, Artero S, Touchon J. Classification criteria for mild cognitive impairment: a population-based validation study[J]. Neurology, 2001,56: 37,42.
  • 9Luis CA, Loewenstein DA, Acevedo A, Barker WW, Duara R. Mild cognitive impairment: directions for future research[J]. Neurology, 2003,61(4):438-44.
  • 10Daly E, Zaitchik D, Copeland M, Schmahmann J, Gunther J, Albert M. Predicting conversion of Alzheimer's disease using standard clinical information[J]. Arch Neurol, 2000,57:675,680.

共引文献15

同被引文献61

引证文献4

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部